{"id":"W3179687460","doi":"10.1016/j.thromres.2021.06.021","title":"Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study","year":2021,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Janssen Pharmaceuticals; Ministero della Salute; Janssen Scientific Affairs; Bayer","keywords":"Medicine; Rivaroxaban; Fondaparinux; Vitamin K antagonist; Cancer; Internal medicine; Dabigatran; Population; Venous thrombosis; Apixaban; Low molecular weight heparin; Venous thromboembolism; Thrombosis; Warfarin; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001569744,0.0003660522,0.001431139,0.0003087359,0.001103157,0.0001096336,0.0003419892,0.0001076335,0.0001791097],"category_scores_gemma":[0.0009265321,0.0001916245,0.0002916984,0.00215818,0.0002361619,0.00005994488,0.000232017,0.0002771423,0.000009850313],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008459708,"about_ca_system_score_gemma":0.0004797564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003570651,"about_ca_topic_score_gemma":0.005541104,"domain_scores_codex":[0.9953397,0.000499667,0.0006348996,0.0006635319,0.001699142,0.001163062],"domain_scores_gemma":[0.9948127,0.001884422,0.0002720765,0.001220605,0.001602289,0.0002079303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007430215,0.1165446,0.5710126,0.0002594674,0.05545459,0.0003165886,0.1569277,0.0008500383,0.006377049,0.0008594872,0.01724151,0.07341339],"study_design_scores_gemma":[0.004263689,0.01034347,0.9519718,0.0002952879,0.00224158,0.000002013897,0.02140186,0.0001656869,0.005611536,0.00007257122,0.003372409,0.0002581138],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822445,0.000688261,0.00001953655,0.008465253,0.0002743618,0.007585013,0.00009716831,0.00007911029,0.0005468009],"genre_scores_gemma":[0.9942075,0.00103975,0.00003310209,0.0005014373,0.0001002,0.003415103,0.00006262082,0.00009024819,0.0005500169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3809592,"threshold_uncertainty_score":0.84847,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1175988438932322,"score_gpt":0.4234543630996354,"score_spread":0.3058555192064032,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}